Latest investigator Stories
--Results Published in Journal of Clinical Oncology Show for the First Time that Adding Entinostat to Antiestrogen Therapy May Be an Effective Approach to Targeting Resistance Pathways in Breast Cancer-- WALTHAM, Mass., May 14, 2013 /PRNewswire/ -- Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on developing novel combination epigenetic strategies to treat cancers that have become resistant to standard treatments, announced today the publication in the Journal of...
The Bladder Cancer Advocacy Network (BCAN) has granted $300,000 to three exceptional up and coming researchers through its Young Investigator Awards program. Bethesda, MD (PRWEB) May 11, 2013 Just as National Cancer Research month begins, the Bladder Cancer Advocacy Network (BCAN) has announced the recipients of its Young Investigator Awards. BCAN’s Scientific Review Group, chaired by Matt Milowsky, MD at the University of North Carolina’s Lineberger Comprehensive Cancer Center,...
Michael Dyer, Ph.D., of St. Jude Children's Research Hospital, has been recognized as one of the nation's leading biomedical researchers by the Howard Hughes Medical Institute MEMPHIS, Tenn., May 9, 2013 /PRNewswire-USNewswire/ -- Michael Dyer, Ph.D., a scientist at St. Jude Children's Research Hospital, has been selected as a Howard Hughes Medical Institute (HHMI) investigator. Dyer is one of 27 scientists nationwide chosen for the recognition from among 1,155 applicants. There are...
NEW YORK, April 23, 2013 /PRNewswire/ -- Intralinks® Holdings, Inc. (NYSE: IL), a leading, global SaaS provider of inter-enterprise content management and collaboration solutions, today announced the results of the 2013 Intralinks Global Investigator Site Survey. The survey looked at how clinical investigator sites currently perceive clinical web portals. The findings revealed that 80% of respondents agreed that a single web portal with one login to access studies across multiple...
RARITAN, N.J., Nov. 15, 2012 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen R&D) today announced the establishment of a global cross-pharmaceutical Investigator Databank designed to improve efficiencies of industry-sponsored clinical trials. Merck and Eli Lilly and Company are the first two companies to join Janssen in this effort. (Logo: http://photos.prnewswire.com/prnh/20120117/LA36598LOGO) The new Investigator Databank, established as part of this...
MADISON, Wis., Nov. 7, 2012 /PRNewswire/ -- The fall release of Allegro CTMS@Site, the clinical trial management system (CTMS) built for investigator sites and research groups, is rich with new features that aim to ease the workload of busy site staff. One key enhancement, much-anticipated by prospects and customers alike, is the addition of patient recruitment campaign functionality. (Logo: http://photos.prnewswire.com/prnh/20101118/CG04162) Sites are faced with many options for...
Foundation Recognizes 2012 Investigator Award Recipients at Annual Dinner CHICAGO, Oct. 23, 2012 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that it is accepting letters of intent for its 2012 PFF Research Fund grants. Letters of intent will be accepted until Monday, November 26, 2012. One of the primary goals of the PFF Research Fund is to support research that will ultimately lead to successful therapies for pulmonary fibrosis (PF). As...
SAN DIEGO, Oct. 9, 2012 /PRNewswire/ -- Bioanalytical and pharmacokinetic specialty Contract Research Organization (CRO) MicroConstants announced today the successful completion of a five-day inspection by the United States Food and Drug Administration (FDA) for compliance with Good Laboratory Practice (GLP) regulations. On September 20, 2012, an investigator from the FDA visited MicroConstants' San Diego facility for a routine inspection to assess the CRO's overall compliance with...
Day to highlight innovative technologies and products being developed across Tufts Medical Center's research enterprise BOSTON, Sept. 4, 2012 /PRNewswire-USNewswire/ -- Tufts Medical Center announced today that it will host its inaugural INNOVATION Day on Wednesday September 12, 2012, from 1:00 p.m. - 5:30 p.m. in the Tufts Medical Center Wolff Auditorium in Boston. Investors are invited to attend the Forum, which will highlight the groundbreaking and commercially relevant...
ANN ARBOR, Mich., July 9, 2012 /PRNewswire-USNewswire/ -- The inaugural $100,000 Taubman Prize for Excellence in Translational Medical Science has been awarded to Harry Dietz, M.D., of the Johns Hopkins University, the University of Michigan's A. Alfred Taubman Medical Research Institute announced today. Dietz, a cardiologist and genetics researcher, has made groundbreaking progress in the understanding of aortic aneurysm and related tissue disorders. His lab is the first to...
